Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration

XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

30-year bond yield now highest in 20+ years

The 30-year U.S. Treasury bond yield hit a two-decade high on Thursday, before falling later in the morning. The yield on the 30-year bond reached 5.45 percent during late morning trading, the highest…

More from Thursday 24 September →